Non hormonal contraception;Contraceptions non hormonales

Revue du Praticien

Volumn 58, Issue 1, 2008, Pages

  Robin, Geoffroy ^b   Letombe, Brigitte ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; SPERMICIDAL AGENT;

CONDOM; CONTRACEPTION; FRANCE; HUMAN; INFECTION PREVENTION; INFERTILITY; MALE INFERTILITY; MEDICAL PRACTICE; REVIEW; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CAP;

EID: 38849174862     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Anaes et Afssaps. Stratégies de choix des méthodes contraceptives chez la femme (2004). www.has-sante.fr
2. World Health Organisation. Mechanism of action, safety and efficacy of intrauterine devices. Geneva: WHO, 1987.
3. Segal SJ, Alvarez-Sanchez F, Adejuwon CA, Brache de Mejia V, Leon P, Faundes A. Absence of chorionic gonadotropin in sera of women who use intrauterine devices. Fertil Steril 1985;44:214-8.
4. Boudineau MO, Multon O, Lopes P. Contraception par dispositifs intrautérins. EMC. Paris, Elsevier, ed. Gynécologie. Vol. 738-A-09.2001:1-7.
5. Trussell J. Contraceptive failures in the united states. Contraception 2004;70:89-96.
6. Moreau C, Trussell J, Rodriguez G, Bajos N, Bouyer J. Contraceptive failure rates in France: results from a population-based survey. Hum Reprod 2007;22:2422-7.
7. Thonneau P, Almont T, de la Rochebrochard E, Maria B. Risk factors for IUD failure: results of a large multicentre case-control study. Hum Reprod 2006;21:2612-6.
8. Walsh T, Grimes D, Frezieres R, et al. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. Lancet 1998;351:1005-8.
9. Grimes DA, Hubacher D, Lopez LM, Schulz KF. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev 2006: CD006034.
10. Gareen IF, Greenland S, Morgenstern H. Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, 1974-1990. Epidemiology 2000;11:589-97.
11. Mosure DJ, Berman S, Kleinbaum D, Halloran ME. Predictors of Chlamydia trachomatis infection among female adolescents: a longitudinal analysis. Am J Epidemiol 1996;144:997-1003.
12. Zhou L, Xiao B. Emergency contraception with Multiload Cu-375 SL IUD: a multicenter clinical trial. Contraception 2001;64:107-12.
13. Shain RN, Perdue ST, Piper JM, et al. Behaviors changed by intervention are associated with reduced STD recurrence: the importance of context in measurement. Sex Transm Dis 2002 29:520-9.
14. Cramer DW, Goldman MB, Schiff I, et al. The relationship of tubal infertility to barrier method and oral contraceptive use. JAMA 1987;257:2446-50.
15. Huyghe E, Nohra J, Vezzosi D, et al. Contraceptions masculines non déférentielles : revue de la littérature. Prog Urol 2007;17:156-64.
16. Farr G, Gabelnick H, Sturgen K, Dorflinger L. Contraceptive efficacy and acceptability of the female condom. Am J Public Health 1994;84:1960-4.
17. World Health Organisation. The safety and feasibility of female condom reuse: report of a WHO consultation. Geneva : WHO, 2002.
18. Gazave J. Les facteurs modifiant les résistances de membranes cellulaires. Med Prat 1971;431:53-7.
19. Erny R, Siboni C. Les tampons au chlorure de benzalkonium. Tolérance locale et effets sur la glaire cervicale. J Gynecol Obstet Biol Reprod (Paris) 1983;12:767-74.
20. Collier F, Letombe B. Contraception naturelle et chimique de la femme. EMC. Paris, Elsevier Ed. Gynécologie. Vol. 738-A-11. 1998:1-4.
21. Trussell J, Strickler J, Vaughan B. Contraceptive efficacy of the diaphragm, the sponge and the cervical cap. Fam Plann Perspect 1993;25:100-5, 135.